Summary by Moomoo AI
On October 10, 2024, multiple GSK executives and Persons Closely Associated (PCAs) acquired ordinary shares through dividend reinvestment under the Company's Share Reward Plan. The transactions were executed on the London Stock Exchange at £15.2563 and £15.3577 per share.Key participants included CEO Emma Walmsley (26 shares), President Corporate Development David Redfern (71 shares), CEO of ViiV Healthcare Deborah Waterhouse (58 shares), and Company Secretary Victoria Whyte (71 shares in total). Other executives including the Chief People Officer, Chief Commercial Officer, and various SVPs also participated in smaller volumes.Notable PCA transactions included Iain Whyte, PCA of Company Secretary Victoria Whyte, who acquired 1,105 shares at £15.3577, representing the largest single transaction in this dividend reinvestment event.
